Loading...
ROCO
6578
Market cap30mUSD
Jul 09, Last price  
16.40TWD
1D
-0.61%
1Q
-8.38%
Jan 2017
-39.59%
IPO
-45.17%
Name

Dabomb Protein Corp

Chart & Performance

D1W1MN
ROCO:6578 chart
P/E
P/S
3.17
EPS
Div Yield, %
2.44%
Shrs. gr., 5y
16.84%
Rev. gr., 5y
-12.56%
Revenues
309m
-8.43%
646,599,000605,222,000470,629,000433,630,000384,413,000337,824,000309,335,000
Net income
-69m
L
21,192,0007,193,000-62,446,000-44,664,000-57,025,00011,637,000-69,338,000
CFO
17m
-65.00%
33,260,00013,411,000-44,253,00019,706,0006,506,00047,554,00016,646,000
Dividend
Jul 08, 20250.4 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DaBomb Protein Biotech Corp. is a specialized biotechnology enterprise primarily dedicated to developing and commercializing antibiotic replacements for the animal health industry. Its extensive product range includes plant-based proteins such as DaBomb-P (Aqua) and DaBomb-P (Livestock), alongside specific antibiotic alternative solutions like DBT-100 HT and DBT-100 LS. The company also manufactures pet care products, featuring LACTOTIDES HEALTH A+ and Liqui-TIDE bandages. Founded in 2001 and headquartered in Tainan, Taiwan, the firm adopted its current name, DaBomb Protein Biotech Corp., in October 2023, having previously operated as DaBomb Protein Corp.
IPO date
Jul 20, 2016
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT